19036, Glenolden, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 19036, Glenolden, Pennsylvania is 91 when comparing 34,000 ZIP Codes in the United States.

An estimate of 94.20 percent of the residents in 19036 has some form of health insurance. 37.37 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 75.72 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 19036 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 2,837 residents under the age of 18, there is an estimate of 4 pediatricians in a 20-mile radius of 19036. An estimate of 40 geriatricians or physicians who focus on the elderly who can serve the 2,075 residents over the age of 65 years.

In a 20-mile radius, there are 35,117 health care providers accessible to residents in 19036, Glenolden, Pennsylvania.

The analysis below provides a hypothetical ‘Prostate Cancer Score’ assessment for primary care physicians (PCPs) in the 19036 ZIP code (Glenolden, PA) and evaluates the availability of primary care services, with a focus on factors relevant to prostate cancer detection and management. This score is a conceptual framework, and actual scores would depend on a comprehensive data collection and analysis process.

The core of the ‘Prostate Cancer Score’ for each PCP would encompass several key metrics. First, the *screening rate* for prostate-specific antigen (PSA) tests among eligible male patients would be assessed. This reflects a doctor's commitment to early detection, a critical factor in successful prostate cancer treatment. The score would also consider the *referral rate* to urologists for patients with elevated PSA levels or other concerning symptoms. Prompt and appropriate referrals are vital for timely diagnosis and intervention. The *patient education* provided regarding prostate cancer risks, screening guidelines, and treatment options would be another crucial element. Physicians who actively engage patients in informed decision-making would receive higher scores. Finally, the score would incorporate the *use of evidence-based guidelines* in prostate cancer management, reflecting a commitment to best practices.

Glenolden, PA (ZIP code 19036), is a suburban community, and the availability of primary care is a crucial factor influencing the ‘Prostate Cancer Score’ for the area. The *physician-to-patient ratio* is a fundamental indicator. A low ratio, indicating a scarcity of PCPs, can lead to longer wait times for appointments, potentially delaying screenings and follow-up care. Conversely, a higher ratio suggests greater accessibility. Publicly available data, such as that from the Health Resources and Services Administration (HRSA), would be used to estimate the physician-to-patient ratio for the 19036 ZIP code.

Standout practices within the 19036 area would be identified based on the metrics mentioned above. Practices with high PSA screening rates, prompt referral processes, and comprehensive patient education programs would be recognized. These practices might also be distinguished by their commitment to using electronic health records (EHRs) and patient portals, which can improve communication and streamline care. The ‘Prostate Cancer Score’ would reflect these differences, providing a comparative analysis of primary care providers in the area.

Telemedicine adoption is another significant factor. Practices that offer telemedicine consultations, especially for follow-up appointments or discussing test results, would likely receive higher scores. Telemedicine can improve access to care, particularly for patients with mobility issues or those who find it difficult to travel. It can also facilitate more frequent communication between patients and their physicians, potentially leading to earlier detection of problems. The extent of telemedicine adoption would be assessed by examining the availability of virtual appointments, the use of remote monitoring tools, and the integration of telemedicine into the practice's workflow.

The availability of mental-health resources is also relevant. Prostate cancer diagnosis and treatment can be emotionally challenging, and access to mental-health support is essential for patients' well-being. Practices that integrate mental-health services into their care models, either through in-house therapists or referrals to external providers, would be viewed favorably. The ‘Prostate Cancer Score’ would consider the availability of these resources and the extent to which physicians screen patients for symptoms of depression or anxiety.

The analysis would also consider the *demographics* of the 19036 ZIP code. The age distribution of the male population is particularly important, as prostate cancer risk increases with age. The analysis would also consider the racial and ethnic makeup of the population, as there are disparities in prostate cancer incidence and mortality rates. The ‘Prostate Cancer Score’ would be adjusted to account for these factors, ensuring that the assessment is fair and reflects the specific needs of the community.

The *insurance coverage* landscape in Glenolden would also be considered. The analysis would identify practices that accept a wide range of insurance plans, including Medicare and Medicaid, to ensure that all residents have access to care. This would be crucial for patients who may not have the financial resources to pay for screening and treatment out-of-pocket. Practices that actively assist patients with navigating the insurance system and accessing financial assistance programs would be recognized.

The *patient experience* would be another factor in the analysis. Patient satisfaction surveys, online reviews, and feedback from community organizations would be used to assess the quality of care provided by each practice. Practices with positive patient experiences, as reflected in these sources, would receive higher scores. This would encompass factors such as wait times, the friendliness of staff, and the overall ease of accessing care.

The ‘Prostate Cancer Score’ would be a dynamic tool, updated regularly to reflect changes in the healthcare landscape. As new guidelines and treatment options emerge, the scoring criteria would be adjusted to ensure that the assessment remains relevant and accurate. The analysis would also be expanded to include additional factors, such as the use of advanced imaging techniques and the availability of clinical trials.

The final ‘Prostate Cancer Score’ for each PCP would be presented in a clear and concise format, along with supporting data and analysis. The score would be designed to be easily understood by both patients and healthcare professionals. The goal is to provide patients with the information they need to make informed decisions about their healthcare and to encourage PCPs to improve the quality of care they provide.

The ‘Prostate Cancer Score’ analysis, combined with data on primary care availability in Glenolden, PA, provides a valuable tool for assessing the quality of prostate cancer care in the community. This framework can be used to identify areas for improvement and to promote better health outcomes for residents.

To visualize the ‘Prostate Cancer Score’ rankings and explore the healthcare landscape in Glenolden and surrounding areas, we encourage you to utilize CartoChrome maps. CartoChrome provides interactive mapping solutions that can help you visualize data, identify healthcare resources, and make informed decisions about your health.